Skip to main content
. 2017 Apr 6;8(20):33683–33693. doi: 10.18632/oncotarget.16898

Figure 5. Raloxifene inhibited STAT3 translocation to nucleus induced by IL-6 in Hep-3B cancer cells.

Figure 5

After serum-free overnight, Hep-3B liver cancer cells were pretreated with Raloxifene for 2 h, followed by IL-6 (50 ng/mL) induced for another 30 min, then processed of STAT3 nuclear translocation detection by immunofluorescence staining.